Statins could help control MS
Early trial results conducted by researchers at the University College London show that statins, which are generally used to treat high cholesterol, may also help MS patients slow progression of the disease and reduce symptoms. The research, published in The Lancet, focuses on late-stage MS, called secondary-progressive MS.
For their phase two trial, the research team randomly assigned 140 people with secondary progressive MS to receive either 80 mg of a statin called simvastatin or a placebo for two years. The high, daily dose of simvastatin was well tolerated and slowed brain shrinkage by 43 percent over two years compared with the placebo.
The researchers believe statins may have anti-inflammatory and neuroprotective properties that can guard the nerves from damage. While promising, larger clinical trials will be needed to confirm the safety and effectiveness of this treatment.